Robby Markwart
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 4
- SARS-CoV-2 detection and testing 2
-
- Sepsis Diagnosis and Treatment 2
- Co-authors
- Tim Eckmanns (13 shared papers)Olaniyi Ayobami (8 shared papers)Niklas Willrich (7 shared papers)Thomas Harder (3 shared papers)Carolin Fleischmann-Struzek (2 shared papers)Benedetta Allegranzi (2 shared papers)Felix Reichert (2 shared papers)Alessandro Cassini (2 shared papers)
- Journals
- Emerging Microbes & Infections (3 papers)Antimicrobial Resistance and Infection Control (3 papers)Eurosurveillance (2 papers)BMJ Open (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Robby Markwart
31 papers receiving 1.5k citations
Robby Markwart's Hit Papers
Peers
Comparison fields: 5 of 117
- Applied Microbiology and Biotechnology 161
- Molecular Medicine 292
- Clinical Biochemistry 148
- Critical Care and Intensive Care Medicine 76
- Infectious Diseases 260
Countries citing papers authored by Robby Markwart
This map shows the geographic impact of Robby Markwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby Markwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby Markwart more than expected).
Fields of papers citing papers by Robby Markwart
This network shows the impact of papers produced by Robby Markwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby Markwart. The network helps show where Robby Markwart may publish in the future.
Co-authors
The 25 scholars most cited alongside Robby Markwart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis Hit paper breakdown → | 2021 | 257 |
| 2 | Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis Hit paper breakdown → | 2020 | 239 |
| 3 | 2019 | 127 | |
| 4 | 2022 | 115 | |
| 5 | 2020 | 112 | |
| 6 | 2015 | 96 | |
| 7 | 2019 | 90 | |
| 8 | 2021 | 71 | |
| 9 | 2014 | 55 | |
| 10 | 2020 | 49 | |
| 11 | 2021 | 47 | |
| 12 | 2021 | 30 | |
| 13 | 2016 | 29 | |
| 14 | 2021 | 29 | |
| 15 | 2013 | 23 | |
| 16 | 2013 | 21 | |
| 17 | 2023 | 20 | |
| 18 | 2017 | 20 | |
| 19 | 2019 | 19 | |
| 20 | 2016 | 19 |
About Robby Markwart
Robby Markwart is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Sepsis Diagnosis and Treatment (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (161 citations), Molecular Medicine (292 citations), Clinical Biochemistry (148 citations), Critical Care and Intensive Care Medicine (76 citations) and Infectious Diseases (260 citations). Robby Markwart has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Tim Eckmanns, Olaniyi Ayobami, Niklas Willrich, Thomas Harder, Carolin Fleischmann-Struzek, Benedetta Allegranzi, Felix Reichert, Alessandro Cassini, Annicka Reuß and Ignacio Rubio. Their work appears in journals such as Emerging Microbes & Infections, Antimicrobial Resistance and Infection Control, Eurosurveillance, BMJ Open and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.